MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

RLMD Relmada Therapeutics Forecast, Technical & Fundamental Analysis

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

Industry Biotechnology
RLMD
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For RLMD
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RLMD
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For RLMD
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

RLMD is expected to report earnings to fall 7.64% to -66 cents per share on March 25

Relmada Therapeutics RLMD Stock Earnings Reports
Q4'24
Est.
$-0.67
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.24
Q1'24
Beat
by $0.26
Q4'23
Missed
by $0.01
The last earnings report on November 07 showed earnings per share of -72 cents, missing the estimate of -68 cents. With 375.24K shares outstanding, the current market capitalization sits at 10.91M.
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2222 Ponce de Leon Boulevard
Phone
+1 786 629-1376
Employees
20
Web
https://www.relmada.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENTO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-6.97%
ENTO - RLMD
35%
Loosely correlated
-3.95%
ARGNF - RLMD
31%
Poorly correlated
N/A
CANF - RLMD
28%
Poorly correlated
-5.96%
AVIR - RLMD
27%
Poorly correlated
+1.94%
ATXS - RLMD
27%
Poorly correlated
-1.24%
More